+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Antibiotic Market - Forecasts from 2019 to 2024

  • ID: 4835414
  • Report
  • July 2019
  • Region: Global
  • 102 pages
  • Knowledge Sourcing Intelligence LLP
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • MORE
The global antibiotic market is projected to grow at a CAGR of 2.89% to reach a market value of US$69.970 billion by 2024. The global antibiotics market is poised to grow at a sustainable rate in the forecast period due to the prevalence of microbial infections, growing research and development investment, rising healthcare expenditure and growing pharmaceutical industry. North America and Europe are expected to hold a significant market share due to the early adoption of innovations, the highest healthcare spending of the United States and the presence of major industry players in these regions. However, rising concerns of antibiotic resistance may hinder the market growth during the forecast period.

Drivers

Prevalence of microbial infections
Growing pharmaceutical industry
Increasing health expenditure worldwide

Restraints

Stringent regulatory procedures regarding approval of drugs and medical devices
Growing concerns regarding antibiotic resistance

Industry Updates

On June 25, 2019, Abbvie Inc. the company announced that it has entered into a definitive agreement with Allergan regarding its acquisition. The company will acquire Allergan in a cash transaction of USD 63 billion (approximately).

Pfizer, Inc., in its 2017-18 annual report announced that the company continues to lead the antibiotic industry and comprises of having the widest product portfolio for anti-infectives. In addition, the company is making certain strategic investments for the development of new therapies in the future.

Major industry players profiled as part of the report are GlaxoSmithKline plc., Pfizer Inc., Novartis Pharmaceuticals Corporation, AbbVie Inc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., MELINTA THERAPEUTICS, INC., Cipla Inc., Sun Pharmaceutical Industries Ltd., and Dr. Reddy’s Laboratories Ltd.

Segmentation

The global antibiotic market has been analyzed through following segments:

By Type

Penicillin
Cephalosporins
Macrolides
Others

By Geography

North America
USA
Canada
Mexico

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • MORE
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL ANTIBIOTIC MARKET BY TYPE
5.1. Penicillins
5.2. Cephalosporins
5.3. Macrolides
5.4. Others

6. GLOBAL ANTIBIOTIC MARKET BY GEOGRAPHY
6.1. North America
6.1.1. USA
6.1.2. Canada
6.1.3. Mexico
6.2. South America
6.2.1. Brazil
6.2.2. Argentina
6.2.3. Others
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. United Kingdom
6.3.4. Spain
6.3.5. Others
6.4. Middle East and Africa
6.4.1. Saudi Arabia
6.4.2. Israel
6.4.3. Others
6.5. Asia Pacific
6.5.1. China
6.5.2. Japan
6.5.3. South Korea
6.5.4. India
6.5.5. Others

7. COMPETITIVE INTELLIGENCE
7.1. Competitive Benchmarking and Analysis
7.2. Recent Investments and Deals
7.3. Strategies of Key Players

8. COMPANY PROFILES
8.1. GlaxoSmithKline plc.
8.2. Pfizer Inc.
8.3. Novartis Pharmaceuticals Corporation
8.4. AbbVie Inc.
8.5. Gilead Sciences, Inc.
8.6. F. Hoffmann-La Roche Ltd.
8.7. MELINTA THERAPEUTICS, INC. - THE ANTIBIOTICS COMPANY
8.8. Cipla Inc.
8.9. Sun Pharmaceutical Industries Ltd.
8.10. Dr. Reddy's Laboratories Ltd.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Novartis Pharmaceuticals Corporation
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • MELINTA THERAPEUTICS, INC.
  • Cipla Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll